Philip D. Chung
101 College Street, Suite 5R406
Toronto, ON M5G1L7, Canada
Toronto, ON M5G1L7, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer.
Journal: Nature communications
Published: June 22, 2022
A temporal in vivo catalog of chromatin accessibility and expression profiles in pineoblastoma reveals a prevalent role for repressor elements.
Journal: Genome research
Published: June 17, 2022
A racemosin B derivative, C25, suppresses breast cancer growth via lysosomal membrane permeabilization and inhibition of autophagic flux.
Journal: Biochemical pharmacology
Published: November 03, 2021
Hypophosphorylated pRb knock-in mice exhibit hallmarks of aging and vitamin C-preventable diabetes.
Journal: The EMBO journal
Published: September 17, 2020
Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy.
Journal: Nature communications
Published: January 02, 2019
CDC25 as a common therapeutic target for triple-negative breast cancer - the challenges ahead.
Journal: Molecular & cellular oncology
Published: May 16, 2018
Mitochondrial OXPHOS Induced by RB1 Deficiency in Breast Cancer: Implications for Anabolic Metabolism, Stemness, and Metastasis.
Journal: Trends in cancer
Published: June 26, 2017
RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation.
Journal: The Journal of clinical investigation
Published: February 18, 2015
Last Updated: 09/26/2026